AzTrials
AzTrials

FatigueNCT03753984

Effects of Low-level Laser Therapy in the Fatigue Muscle of Healthy Individual and Spastic Individuals

A study testing Low-level laser therapy in people with Fatigue and Stroke Sequelae, run by Universidade do Vale do Paraíba at 1 site in Brazil.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Muscle fatigue is caused by biochemical changes that modify the mechanics of muscle contraction, which result in negative changes in the performance of the contraction. The objective of this study is to evaluate the effects of LLLT on brachial biceps muscle fatigue in healthy individuals and individuals with spastic… Read more about this study

Who is it for?
Ages 20 to 80 yearsHealthy volunteers can take part
Conditions the study is for
Fatigue, Stroke Sequelae
What is being tested?
Low-level laser therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteBrazil
Study dates
1 Sep 2018to 1 Mar 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 80 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Preserved cognition, and preservation of the ability to respond to verbal stimul;
  • To present the "insufficient active" or "active" indices on the scale of the International Questionnaire of Physical Activity.
  • Individuals with medical diagnosis of stroke;
  • Individuals with physiotherapeutic diagnosis of spastic hemiparesis with brachial predominance;
  • Preserved cognition and preservation of the ability to respond to verbal stimuli;
  • Injury time: after 12 months;
  • Patients with a maximum of 2 degree spasticity according to the Modified Ashworth Scale and minimum muscle strength of 1 in the biceps brachii muscle.

Who cannot join

  • Possess musculoskeletal impairment of the dominant upper limb;
  • Practice physical activity with load (bodybuilding);
  • Presence of active infection and eruptions in the dominant upper limb;
  • Limiting pain that makes it impossible to perform the evaluation protocol;
  • Ingestion of analgesic and / or anti-inflammatory drugs and / or drugs containing corticosteroids or steroids.
  • Fitzpatrick classification: Phototypes V and VI;
Show all 20Show fewer
  • Presence of malignant neoplastic lesion;
  • Presence of active infection and eruptions at the electrode application site;
  • Hypoesthesia and / or hyperesthesia and / or anesthesia of the limb in which TLBI will be applied.
  • Presence of active infection and eruptions in the dominant upper limb;
  • Limiting pain that makes it impossible to perform the evaluation protocol;
  • Ingestion of analgesic and / or anti-inflammatory drugs and / or drugs containing corticosteroids or steroids.
  • Fitzpatrick classification: Phototypes V and VI;
  • Presence of malignant neoplastic lesion;
  • Presence of active infection and eruptions at the electrode application site;
  • Hypoesthesia and / or hyperesthesia and / or anesthesia of the limb to be treated;
  • Muscular contractures and joint deformities;
  • Uncontrolled arterial hypertension;
  • Individuals with other associated neurological and / or orthopedic disorders;
  • Wernick or Broca's aphasia.

Trial locations and contacts

1 site in 1 country.

Gabriela S Souza contact

5512997232806

fpupio@univap.br

Brazil1 site, 1 recruiting
  • Universidade do Vale do Paraiba

    São José dos Campos, São Paulo, 12.244-000

    Gabriela S Souza, 5512997232806, gabrielasouza507@yahoo.com.br

    Recruiting

Other trials in Brazil

About this study

Official title: Analysis of the Effects of Low-level Laser Therapy in the Muscular Fadiga of the Braquial Biceps Muscle of Healthy Individual and Spastic Individuals

Muscle fatigue is caused by biochemical changes that modify the mechanics of muscle contraction, which result in negative changes in the performance of the contraction. The objective of this study is to evaluate the effects of LLLT on brachial biceps muscle fatigue in healthy individuals and individuals with spastic hemiparesis. The study will consist of three groups (Control Group, Placebo Group and LLLT Group) and all individuals will go through all groups, following the criteria of randomization. The protocol consists of LLLT application in the dominant side brachialis muscle in healthy subjects and on the hemiparetic side of post-stroke individuals, prior to performing the Isometric Maximum Voluntary Contraction (IMVC) for 50 seconds in the isokinetic dynamometer. Will be evaluated pain, myoelectric activity associated with muscular torque, local temperature and blood lactate concentration.

Read the detailed description

Muscle fatigue is caused by biochemical changes that modify the mechanics of muscle contraction, which result in negative changes in the performance of the contraction. Several resources are studied in order to mitigate this situation, among them we can mention the Low Level-Laser Therapy (LLLT), which has demonstrated positive effects in the treatment of muscle disorders and fatigue prevention. The effects of LLLT are being studied in healthy individuals with fibromyalgia and athletes, currently studies are being performed on spastic muscles with post-stroke patients (post-stroke). The objective of this study is to evaluate the effects of LLLT on brachial biceps muscle fatigue in healthy individuals and individuals with spastic hemiparesis. A double-blind, cross-sectional, comparative, randomized, double-blind clinical trial will be conducted. Phase I will consist of 30 healthy individuals and Phase II will be composed of 30 post-stroke individuals. The study will consist of three groups (Control Group, Placebo Group and LLLT Group) and all individuals will go through all groups, following the criteria of randomization. The protocol consists of LLLT application in the dominant side brachialis muscle in healthy subjects and on the hemiparetic side of post-stroke individuals, prior to performing the Isometric Maximum Voluntary Contraction (IMVC) for 50 seconds in the isokinetic dynamometer. The pain intensity will be evaluated through the Visual Analog Pain Scale, the myoelectric activity through the surface electromyography associated with the evaluation of the muscular torque through the isokinetic dynamometer. The local temperature will be evaluated by infrared thermography and blood lactate concentration by means of the lactimeter, which will be measured at four different times, prior to the application of the laser (basal collection) and 3, 15 and 25 minutes after IMVC.

Being tested
Low-level laser therapy
Keywords
Fatigue, Low-level Laser Therapy, Stroke, Infrared thermograpy
Medical subject headings
Fatigue, Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Low-level laser therapyOther

    In both arms will be applied Low-level laser therapy and induced muscle fatigue.

Study groups in NCT03753984
Study groupRoleWhat they receive
Healthy groupExperimentalThe protocol consists of Low-level laser therapy (LLLT) application in the dominant side brachialis muscle in healthy subjects prior to performing the Isometric Maximum Voluntary Contraction (IMVC) for 50 seconds in the isokinetic dynamometer and will be analize Visual Analog Pain Scale, electromyography associated with the evaluation of the muscular torque through the isokinetic dynamometer, local infrared thermography and blood lactate concentration by means of the lactimeter, which will be measured at four different times, prior to the application of the laser (basal collection) and 3, 15 and 25 minutes after IMVC. All the participants will pass for three groups: Control group (not will be applicate LLLT), Placebo group (laser will be off) and LLLT group (will be applicate LLLT).
Receives: Other: Low-level laser therapy
Post stroke groupExperimentalThe protocol consists of Low-level laser therapy (LLLT) application in the hemiparetic side brachialis muscle post stroke individuals prior to performing the Isometric Maximum Voluntary Contraction (IMVC) for 50 seconds in the isokinetic dynamometer and will be analize Visual Analog Pain Scale, surface electromyography with the evaluation of the muscular torque through the isokinetic dynamometer, local infrared thermography and blood lactate concentration, which will be measured at four different times, prior to the application of the laser (basal collection) and 3, 15 and 25 minutes after IMVC. All the participants will pass for three groups: Control group (not will be applicate LLLT), Placebo group (laser will be off) and LLLT group (will be applicate LLLT).
Receives: Other: Low-level laser therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes in pain sensation

    To analize the pain. The scale is composed of a horizontal line with a scale of 0 to 10, with 0 representing no pain and 10 representing the worst possible pain.

    Measured: Baseline (before test) and will be assessed from the beginning to the end of the test (50 seconds).

  2. Surface electromyograph

    To analize the myoelectric activity. The surface electrodes will be placed in pairs on the muscular belly of the biceps and triceps brachii muscles, following the longitudinal direction of the muscle fibers.

    Measured: Will be assessed from the beginning to the end of the test (50 seconds).

  3. Analyze the behavior of the local temperature (Infra-red thermography)

    To analize the local temperature.

    Measured: Baseline (Before test) and will be assessed from the beginning to the end of the test (50 seconds).

  4. To evaluate changes in lactate concentration through lactimeter.

    A collection of blood lactate levels will be performed at four different times.

    Measured: Baseline (before test) and after the test (3, 15 and 25 minutes after the test)

  5. Isokinetic dynamometer

    To analize muscle torque

    Measured: Will be assessed from the beginning to the end of the test (50 seconds).

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Nov 2018
  2. Study start1 Sep 2018
  3. Primary completion1 Jun 2019
  4. Study completion1 Mar 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Care provider, Outcomes assessor
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03753984
Sponsor's protocol ID
UNIVAP
Status last verified
Nov 2018
First submitted
31 Oct 2018
Last updated
15 Jul 2019
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Low-level laser therapy in people with Fatigue and Stroke Sequelae, run by Universidade do Vale do Paraíba at 1 site in Brazil.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 20 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 15 Jul 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Gabriela S Souza (5512997232806, gabrielasouza507@yahoo.com.br), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes in pain sensation (time frame: Baseline (before test) and will be assessed from the beginning to the end of the test (50 seconds).). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Jul 2019; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in